pI: 5.2726 |
Length (AA): 263 |
MW (Da): 27067 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
4 | 255 | 3pk0 (A) | 0 | 251 | 34.00 | 0 | 1 | 1.41797 | -0.65 |
4 | 250 | 1fmc (A) | 5 | 249 | 40.00 | 0 | 1 | 1.47426 | -0.61 |
7 | 263 | 5tf4 (A) | 7 | 267 | 25.00 | 0 | 1 | 1.22679 | -0.01 |
7 | 251 | 2ew8 (A) | 4 | 246 | 43.00 | 0 | 1 | 1.35066 | -0.15 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_130175)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G12800 | short-chain dehydrogenase-reductase B |
Candida albicans | CaO19.11168 | similar to peroxisomal 2,4-dienoyl-CoA reductase |
Candida albicans | CaO19.4157 | SPS19-like orf, peroxisomal 2,4-dienoyl-CoA reductase |
Candida albicans | CaO19.11633 | SPS19-like orf, peroxisomal 2,4-dienoyl-CoA reductase |
Candida albicans | CaO19.3684 | truncated form of SPS19, peroxisomal 2, 4-dienoyl-CoA reductase |
Caenorhabditis elegans | CELE_T05C12.3 | Protein DECR-1.3 |
Caenorhabditis elegans | CELE_W01C9.4 | Protein DECR-1.2 |
Homo sapiens | ENSG00000242612 | 2,4-dienoyl CoA reductase 2, peroxisomal |
Mus musculus | ENSMUSG00000036775 | 2-4-dienoyl-Coenzyme A reductase 2, peroxisomal |
Mycobacterium tuberculosis | Rv0927c | Probable short-chain type dehydrogenase/reductase |
Mycobacterium ulcerans | MUL_4442 | short chain dehydrogenase |
Neospora caninum | NCLIV_046640 | hypothetical protein |
Oryza sativa | 4336980 | Os04g0614000 |
Saccharomyces cerevisiae | YNL202W | Sps19p |
Toxoplasma gondii | TGME49_226300 | 2,4-dienoyl CoA reductase 2, peroxisomal family protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
TGME49_226300 | Toxoplasma gondii | Probably non-essential | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Macaca mulatta | Hydroxysteroid 11-beta dehydrogenase 1 | 140 aa | 28.0% | 132 aa | Compounds | References |
Staphylococcus aureus subsp. aureus MRSA252 | Enoyl-[acyl-carrier-protein] reductase | 256 aa | 27.1% | 262 aa | Compounds | References |
Staphylococcus aureus | Enoyl-[acyl-carrier-protein] reductase [NADPH] | 256 aa | 27.1% | 262 aa | Compounds | References |
Staphylococcus aureus | Enoyl-ACP reductase | 243 aa | 27.3% | 245 aa | Compounds | References |
Bacillus subtilis (strain 168) | Enoyl-[acyl-carrier-protein] reductase [NADH] | 258 aa | 24.6% | 256 aa | Compounds | References |
Staphylococcus aureus (strain NCTC 8325) | Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI | 256 aa | 26.7% | 262 aa | Compounds | References |